0.05
+0.0021(+4.24%)
Currency In USD
| Previous Close | 0.05 |
| Open | 0.05 |
| Day High | 0.05 |
| Day Low | 0.05 |
| 52-Week High | 17.18 |
| 52-Week Low | 0.04 |
| Volume | 1,192 |
| Average Volume | 881,636 |
| Market Cap | 270,089 |
| PE | -0.01 |
| EPS | -5.79 |
| Moving Average 50 Days | 0.29 |
| Moving Average 200 Days | 5.29 |
| Change | 0 |
If you invested $1000 in Vincerx Pharma, Inc. (VINC) since IPO date, it would be worth $0.28 as of May 27, 2025 at a share price of $0.052. Whereas If you bought $1000 worth of Vincerx Pharma, Inc. (VINC) shares 3 years ago, it would be worth $1.57 as of May 27, 2025 at a share price of $0.052.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC
GlobeNewswire Inc.
Apr 17, 2025 8:45 PM GMT
Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025 SAN MATEO, Calif., April 17, 2025 (GLOBE N
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
GlobeNewswire Inc.
Apr 08, 2025 8:05 PM GMT
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as Q
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
GlobeNewswire Inc.
Mar 18, 2025 12:52 PM GMT
SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has entered into a non-binding letter of intent (“LOI”) with Global Digital Holdings Inc., conducting business as QumulusAI, a private